Neuro-Behçet syndrome

Handbook of Clinical Neurology

Volumn 121, Issue , 2014, Pages 1703-1723

  Saip, Sabahattin ^a   Akman Demir, Gulsen ^b   Siva, Aksel ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL BILIM UNIVERSITY   (Turkey)

Author keywords

Beh et's disease; Cerebral venous sinus thrombosis; Differential diagnosis; Nervous system involvement; Neuro Beh et syndrome; Treatment

Indexed keywords

ARTICLE; BEHCET DISEASE; BEHÇET'S DISEASE; CEREBRAL VENOUS SINUS THROMBOSIS; DIFFERENTIAL DIAGNOSIS; HUMAN; NERVOUS SYSTEM INVOLVEMENT; NEURO-BEHÇET SYNDROME; NEUROIMAGING; NEUROLOGIC DISEASE; PATHOLOGY; PROGNOSIS; TREATMENT;

BEHÇET'S DISEASE; CEREBRAL VENOUS SINUS THROMBOSIS; DIFFERENTIAL DIAGNOSIS; NERVOUS SYSTEM INVOLVEMENT; NEURO-BEHÇET SYNDROME; TREATMENT;

BEHCET SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS; NERVOUS SYSTEM DISEASES; NEUROIMAGING; PROGNOSIS;

EID: 84890813058     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-7020-4088-7.00110-3     Document Type: Chapter

References (136)

1. Aguiar de Sousa D., Mestre T., Ferro J.M. Cerebral venous thrombosis in Behçet's disease: a systematic review. J. Neurol. 2011, 258:719-727.
2. Akbulut L., Gur G., Bodur H., et al. Peripheral neuropathy in Behçet disease: an electroneurophysiological study. Clin. Rheumatol. 2007, 26:1240-1244.
3. Akman-Demir G., Bahar S., Baykan-Kurt B., et al. Intracranial hypertension in Behçet's Disease. Eur. J. Neurol. 1996, 3:66-70.
4. Akman-Demir G., Serdaroglu P., Tasci B. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. Brain 1999, 122:2171-2181.
5. Akman-Demir G., Bahar S., Coban O., et al. Cranial MRI in Behçet's disease: 134 examinations of 98 patients. Neuroradiology 2003, 45:851-859.
6. Akman-Demir G., Tüzün E., Içöz S., et al. Interleukin 6 in neuro-Behçet's disease: association with disease subsets and long term outcome. Cytokine 2008, 44:373-376.
7. Akman-Demir G., Ayranci O., Kurtuncu M., et al. Cyclosporine for Behçet's uveitis: is it associated with an increased risk of neurological involvement?. Clin. Exp. Rheumatol. 2008, 26:S84-S90.
8. Akman-Demir G., Saip S., Siva A. Behçet's disease. Curr. Treat. Options Neurol. 2011, 13:290-310.
9. Aktaş E.G., Kaplan M., Ozveren M.F. Basilar artery aneurysm associated with Behçet's disease: a case report. Turk. Neurosurg. 2008, 18:35-38.
10. Al-Araji A., Kidd D.P. Neuro-Behçet's disease: epidemiology, clinical characteristics, and management. Lancet. Neurol. 2009, 8:192-204.
11. Al-Araji A., Siva A., Saip S., et al. Treatment of neuro-Behçet's disease with infliximab. An international multicentre case series of 18 patients. Clin. Exp. Rheumatol. 2010, 28(Suppl 60):S119.
12. Al-Araji A., Sharquie K., Al-Rawi Z. Prevalence and patterns of neurological involvement in Behçet's disease: a prospective study from Iraq. J. Neurol. Neurosurg. Psychiatry 2003, 74:608-613.
13. Albayram S., Saip S., Hasiloglu Z., et al. Evaluation of parenchymal neuro-Behçet's disease using susceptibility weighted imaging. AJNR Am. J. Neuroradiol 2011, 32:1050-1055.
14. Alkan A., Goktan A., Karincaoglu Y., et al. Brain perfusion MRI findings in patients with Behçet's disease. ScientificWorld Journal 2012, Article ID 261502.
15. Arai Y., Kohno S., Takahashi Y., et al. Autopsy case of neuro-Behçet's disease with multifocal neutrophilic perivascular inflammation. Neuropathology 2006, 26:579-585.
16. Atabay C., Erdem E., Kansu T., et al. Eales' disease with internuclear ophthalmoplegia. Ann. Ophthalmol 1992, 24:267-270.
17. Atasoy H.T., Tunc T.O., Unal A.E., et al. Peripheral nervous system involvement in patients with Behçet disease. Neurologist 2007, 13:225-230.
18. Avci O., Kutluay E., Argon M., et al. Subclinical cerebral involvement in Behçet's disease: a SPECT study. Eur. J. Neurol. 1998, 5:49-53.
19. Aykutlu E., Baykan B., Serdaroglu P., et al. Epileptic seizures in Behçet disease. Epilepsia 2002, 43:832-835.
20. Aykutlu E., Baykan B., Akman-Demir G., et al. Headache in Behçet's disease. Cephalalgia 2006, 26:180-186.
21. Behçet H. Uber residivierende, aphtöse, durch ein virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Derm. Woschenscr. 1937, 105:1152-1157.
22. Ben Taarit C., Turki S., Ben Maïz H. Neurological manifestations in Behçet's disease. Forty observations in a cohort of 300 patients. J. Mal. Vasc. 2002, 27:77-81.
23. Berard X., Corpataux J.M., Taoufiq H., et al. Don't trust a vein graft to treat carotid aneurysm in patients with Behçet's disease. J. Vasc. Surg. 2010, 52:471-474.
24. Bogdanova D., Milanov I., Georgiev D. Parkinsonian syndrome as a neurological manifestation of Behçet's disease. Can. J. Neurol. Sci. 1998, 25:82-85.
25. Borhani Haghighi A., Sarhadi S., Farahangiz S. MRI findings of neuro-Behçet's disease. Clin. Rheumatol. 2011, 30:765-770.
26. Bussone G., La Mantia L., Boiardi A., et al. Chorea in Behçet's syndrome. J. Neurol. 1982, 227:89-92.
27. Cavaco S., da Silva A.M., Pinto P., et al. Cognitive functioning in Behçet's disease. Contemporary challenges in autoimmunity. Ann. N Y Acad. Sci. 2009, 1173:217-226.
28. Cetinel B., Obek C., Solok V., et al. Urologic screening for men with Behçet's syndrome. Urology 1998, 52:863-865.
29. Davatchi F., Shahram F., Chams-Davatchi C., et al. Behçet's disease in Iran: analysis of 6500 cases. Int. J. Rheum. Dis. 2010, 13:367-373.
30. Demirkesen C., Öz B., Göksel S. Behçet's disease: pathology. Behçet's Syndrome 2010, 215-242. Springer, New York, Dordrecht Heidelberg London. Y. Yazficfi, H. Yazficfi (Eds.).
31. Direskeneli H., Saruhan-Direskeneli G. Disease mechanisms. Behçet's Syndrome 2010, 243-264. Springer, New York, Dordrecht Heidelberg London. Y. Yazficfi, H. Yazficfi (Eds.).
32. Essaadouni L., Jaafari H., Abouzaid C.H., et al. Neurological involvement in Behçet's disease: evaluation of 67 patients. Rev. Neurol. (Paris) 2010, 166:727-733.
33. Gardner R.C., Schmahmann J.D. Ataxia and cerebellar atrophy - a novel manifestation of neuro-Behçet disease?. Mov. Disord. 2008, 23:308-309.
34. Goodwin J. The Vogt-Koyanagi-Harada syndrome. MedLink Neurology 2010, MedLink Corporation, San Diego, Available at:, (last updated January 2, 2010; accessed 26 March 2011). http://www.medlink.com, S. Gilman (Ed.).
35. Green A.L., Mitchell P.J. Spinal cord neurobehçet's disease detected on magnetic resonace imaging. Australas Radiol. 2000, 44:201-203.
36. Gul A. Behçet's disease as an autoinflammatory disorder. Curr. Drug. Targets. Inflamm. Allergy. 2005, 4:81-83.
37. Gul A. Genome-wide association studies in Behçet's disease: expectations and promises. Clin. Exp. Rheumatol. 2011, 29:S3-S5.
38. Gul A., Ohno S. HLA-B*51 and Behçet disease. Ocul. Immunol. Inflamm. 2012, 20:37-43.
39. Gul A., Hajeer A.H., Worthington J., et al. Evidence for linkageof HLA-B locus in Behçet's disease, obtained using the transmission disequilibrium test. Arthritis Rheum. 2001, 44:239-240.
40. Gul A., Uyar A., Inanc M., et al. A weak association of HLA-B*2702 with Behçet's disease. Genes Immun. 2002, 3:368-372.
41. Gul A., Tugal Tutkun I., Dinarello C.A., et al. Interleukin-1-beta-regulating antibody XOMA052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study. Ann. Rheum. Dis. 2012, 71:563-566.
42. Gunduz T., Emir O., Kurtuncu M., et al. Cognitive impairment in neuro-Behçet's disease and multiple sclerosis: a comparative study. Int. J. Neurosci. 2012, 122:650-656.
43. Hadfield M.G., Aydfin F., Lippman H.R., et al. Neuro-Behçet's disease. Clin. Neuropathol 1997, 16:55-60.
44. Haghighi A.B., Aflaki E., Ketabchi L. The prevalence and characteristics of different types of headache in patients with Behçet's disease, a casecontrol study. Headache 2008, 48:424-429.
45. Hatemi G., Silman A., Bang D., et al. EULAR Expert Committee. EULAR recommendations for the management of Behçet's disease. Ann. Rheum. Dis. 2008, 67:1656-1662.
46. Hatzitolios A., Savopoulos C., Ntaios G., et al. Recurrent peripheral facial paresis may constitute the sole clinical manifestation in neuro-Behçet disease. Neurologist 2008, 14:77.
47. Headache Classification Subcommittee of the International Headache Society The International Classifications of Headache Disorders, 2nd edn (ICHDII). Cephalalgia 2004, 24(Suppl 1):1-160.
48. Heo J.H., Lee S.T., Chu K., et al. Neuro-Behçet's disease mimicking multiple brain tumors: diffusion-weighted MR study and literature review. J. Neurol. Sci. 2008, 264:177-181.
49. Hirohata S. Histopathology of central nervous system lesions in Behçet's disease. J. Neurol. Sci. 2008, 267:41-47.
50. Hirohata S., Isshi K., Oguchi H., et al. Cerebrospinal fluid interleukin-6 in progressive neuro-Behçet's syndrome. Clin. Immunol. Immunopathol 1997, 82:12-17.
51. Hisanaga K. Neuro-neutrophilic disease: neuro-Behçet disease and neuro-Sweet disease. Intern. Med. 2007, 46:153-154.
52. Hisanaga K., Iwasaki Y., Itoyama Y. Neuro-Sweet disease: clinical manifestations and criteria for diagnosis. Neurology 2005, 64:1756-1761.
53. Hiwatashi A., Garber T., Moritani T., et al. Diffusion-weighted MR imaging of neuro-Behçet's disease: a case report. Neuroradiology 2003, 45:468-471.
54. Houman M.H., Hamzaoui-B'Chir S., Ben Ghorbel I., et al. Neurologic manifestations of Behçet's disease: analysis of a series of 27 patients. Rev. Med. Interne. 2002, 23:592-606.
55. Huang W.S., Chiu P.Y., Kao A., et al. Decreased cerebral blood flow in neuro-Behçet's syndrome patients with neuropsychiatric manifestations and normal magnetic resonance imaging - a preliminary report. J. Neuroimaging 2002, 12:355-359.
56. Ideguchi H., Suda A., Takeno M., et al. Neurological manifestations of Behçet's disease in Japan: a study of 54 patients. J. Neurol. 2010, 257:1012-1020.
57. International Study Group for Behçet's Disease Criteria for diagnosis of Behçet's disease. Lancet 1990, 335:1078-1080.
58. International Study Group for Behçet's disease Evaluation of diagnostic (classification) criteria in Behçet's disease - towards internationally agreed criteria. Br. J. Rheumatol 1992, 31:299-308.
59. Kale N., Agaoglu J., Icen M., et al. The presentation of headache in neuro-Behçet's disease: a case-series. Headache 2009, 49:467-470.
60. Kang D.W., Chu K., Cho J.Y., et al. Diffusion-weighted magnetic resonance imaging in neuro-Behçet's disease. J. Neurol. Neurosurg Psychiatry 2001, 70:412-413.
61. Kansu T., Kirkali P., Kansu E., et al. Optic neuropathy in Behçet's disease. J. Clin. Neuroophthalmol 1989, 9:277-280.
62. Karandreas N., Tsivgoulis G., Zambelis T., et al. Urinary frequency in a case of neuro-Behçet disease involving the brainstem - clinical, electrophysiological and urodynamic features. Clin. Neurol. Neurosurg 2007, 109:806-810.
63. Karatas G.K., Onder M., Meray J. Autonomic nervous system involvement in Behçet's disease. Rheumatol Int. 2002, 22:155-159.
64. Kececi H., Akyol M. P300 in Behçet's patients without neurological manifestations. Can J. Neurol. Sci. 2001, 28:66-69.
65. Kidd D. The prevalence of headache in Behçet's syndrome. Rheumatology 2006, 45:621-623.
66. Kidd D., Steuer A., Denman A.M., et al. Neurological complications in Behçet's syndrome. Brain 1999, 122:2171-2181.
67. Kikuchi S., Niino M., Shinpo K., et al. Intracranial hemorrhage in neuro-Behçet's syndrome. Intern. Med. 2002, 41:692-695.
68. Kim D.K., Chang S.N., Bang D., et al. Clinical analysis of 40 cases of childhood-onset Behcet's disease. Pediatr. Dermatol. 1994, 11:95-101.
69. Kizilkilic O., Albayram S., Adaletli I., et al. Endovascular treatment of Behçet's disease-associated intracranial aneurysms: report of two cases and review of the literature. Neuroradiology 2003, 45:328-334.
70. Koç Y., Güllü I., Akpek G., et al. Vascular involvement in Behçet's disease. J. Rheumatol. 1992, 19:402-410.
71. Koçer N., Islak C., Siva A., et al. CNS involvement in neuro-Behçet's syndrome: an MR study. AJNR Am J. Neuroradiol 1999, 20:1015-1024.
72. Kotake S., Higashi K., Yoshikawa K., et al. Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy. Ophthalmology 1999, 106:586-589.
73. Kotter I., Gunaydin I., Batra M., et al. CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A than under other medications results of a retrospective analysis of 117 cases. Clin. Rheumatol 2006, 25:482-486.
74. Krespi Y., Akman-Demir G., Poyraz M., et al. Cerebral vasculitis and ischaemic stroke in Behçet's disease: report of one case and review of the literature. Eur. J. Neurol. 2001, 8:719-722.
75. Kural-Seyahi E., Fresko I., Seyahi N., et al. The long term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003, 82:60-76.
76. Kurtuncu M., Tuzun E., Pehlivan M., et al. Clinical patterns and treatment effect on neuro-Behçet's disease: analysis of 351 patients. Clin. Exp. Rheumatol. 2008, 26(Suppl 50):S43.
77. Lakhanpal S., Tani K., Lie J.T., et al. Behçet's syndrome: a review of Japanese autopsy registry data. Hum. Pathol. 1985, 16:790-795.
78. Lannuzel A., Lamaury I., Charpentier D., et al. Neurological manifestations of Behçet's disease in a Caribbean population: clinical and imaging findings. J. Neurol. 2002, 249:410-418.
79. Matsuo K., Yamada K., Nakajima K., et al. Neuro-Behçet disease mimicking brain tumor. AJNR Am J. Neuroradiol 2005, 26:650-653.
80. Mendoza-Pinto C., Garcia-Carrasco M., Jimenez-Hernandez M., et al. Etiopathogenesis of Behçet's disease. Autoimmun Rev. 2010, 9:241-245.
81. Miller D.H., Ormerod I.E.C., Gibson A., et al. MRI brain scanning in patients with vasculitis: differentiation from multiple sclerosis. Neuroradiology 1987, 29:226-231.
82. Mitsikostas D.D., Sfikakis P.P., Goadsby P.J. A meta analysis for headache in systemic lupus erythematosus. Evidence and the myth. Brain 2004, 127:1200-1209.
83. Mitsui Y., Mitsui M., Urakami R., et al. Behçet disease presenting with neurological complications immediately after conversion from conventional cyclosporin A to microemulsion formulation. Intern. Med. 2005, 44:149-152.
84. Mizuki N., Ota M., Kimura M., et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with BD. Proc. Natl. Acad. Sci. U S A 1997, 94:1298-1303.
85. Mizuki N., Meguro A., Ota M., et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat. Genet. 2010, 42:703-706.
86. Monastero R., Mannino M., Lopez G., et al. Prevalence of headache in patients with Behçet's disease without overt neurological involvement. Cephalalgia 2003, 23:105-108.
87. Morrissey S.P., Miller D.H., Harmszewski R., et al. Magnetic resonance imaging of the central nervous system in Behçet's disease. Eur. Neurol. 1993, 33:287-293.
88. Namer I.J., Karabudak R., Zileli T., et al. Peripheral nervous system involvement in Behçet's disease. Eur. Neurol. 1987, 26:235-240.
89. Nobili F., Cutolo M., Sulli A., et al. Brain functional involvement by perfusion SPECT in systemic sclerosis and Behçet's disease. Ann. N Y Acad. Sci. 2002, 966:409-414.
90. Noel N., Hutié M., Wechsler B., et al. Pseudotumoural presentation of neuro-Behçet's disease: case series and review of literature. Rheumatology (Oxford) 2012, 51:1216-1225.
91. Oktem-Tanor O., Baykan-Kurt B., Gurvit I.H., et al. Neuropsychological follow-up of 12 patients with neuro-Behçet disease. J. Neurol. 1999, 246:113-119.
92. Park D.M. Neurosarcoidosis. MedLink Neurology 2008, MedLink Corporation, San Diego, Available at:, (accessed 1 August 2008). http://www.medlink.com, S. Gilman (Ed.).
93. Park J.H., Jung M.K., Bang C.O., et al. Neuro-Behçet's disease mimicking a cerebral tumor : a case report. J. Korean. Med. Sci. 2002, 17:718-722.
94. Patel A.V., Stickler D.E., Tyor W.R. Neurosarcoidosis. Curr. Treat. Options Neurol. 2007, 9:161-168.
95. Pipitone N., Olivieri I., Padula A., et al. Infliximab for the treatment of neuro-Behçet's disease: a case series and review of the literature. Arthritis Rheum. 2008, 59:285-290.
96. Ramachandran T.R., Shirsat S., Ramachandran A. Cogan's syndrome. MedLink Neurology 2010, MedLink Corporation, San Diego, Available at:, (last updated February 1, 2010; accessed 25 March 2011). http://www.medlink.com, S. Gilman (Ed.).
97. Remmers E., Cosan F., Yohei K., et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23-R-IL12RB2 regions associated with Behçet's disease. Nat. Genet. 2010, 42:689-702.
98. Saadoun D., Wechsler B., Resche-Rigon M., et al. Cerebral venous thrombosis in Behçet's disease. Arthritis Rheum. 2009, 61:518-526.
99. Saadoun D., Wechsler B., Desseaux K., et al. Mortality in Behçet's disease. Arthritis Rheum. 2010, 62:2806-2812.
100. Saip S., Siva A., Altintas A., et al. Headache in Behçet's syndrome. Headache 2005, 45:911-919.
101. Sakane T., Takeno M., Suzuki N., et al. Behçet's disease. N. Engl. J. Med. 1999, 341:1284-1291.
102. Salvarani C., Brown R.D., Calamia K.T., et al. Primary central nervous system vasculitis: analysis of 101 patients. Ann. Neurol. 2007, 62:442-451.
103. Saruhan-Direskeneli G., Yentür S.P., Akman-Demir G., et al. Cytokines and chemokines in neuro-Behçet's disease compared to MS and other neurological disorders. J. Neuroimmunol 2003, 145:127-134.
104. Sarui H., Maruyama T., Ito I., et al. Necrotising myositis in Behçet's disease: characteristic features on magnetic resonance imaging and a review of the literature. Ann. Rheum. Dis. 2002, 61:751-752.
105. Schmolck H. Large thalamic mass due to neuro-Behçet disease. Neurology 2005, 65:436.
106. Sener R.N. Neuro-Behçet's disease: diffusion MR imaging and proton MR spectroscopy. AJNR Am J. Neuroradiol 2003, 24:1612-1614.
107. Serdaroglu P. Neuromuscular manifestations in the course of Behçet's disease. Acta. Myol. 1998, 2:41-45.
108. Serdaroglu P., Yazici H., Özdemir C., et al. Neurological involvement in Behçet's syndrome: a prospective study. Arch. Neurol. 1989, 46:265-269.
109. Sfikakis P.P., Markomichelakis N., Alpsoy E., et al. Anti-TNF therapy in the management of Behçet's disease: review and basis for recommendations. Rheumatology 2007, 46:736-741.
110. Shahien R., Bowirrat A. Neuro-Behçet's disease: a report of sixteen patients. Neuropsychiatr 2010, 6:219-225. Dis Treat. Dove Medical Press Ltd.
111. Shapiro L.S., Farrell J., Borhani Haghighi A. Tocilizumab treatment for neuro-Behçet's disease, the first report. Clin. Neurol. Neurosurg 2012, 114:297-298.
112. Shimojo S., Yamamoto N., Matsuda T., et al. Asymptomatic neuro-Behçet's disease. J. Neuroimaging 1998, 8:59-60.
113. Shugaiv E., Tuzun E., Mutlu M., et al. Mycophenolate mofetil as a novel immunosuppressant in the treatment of Behçet's disease with parenchymal neurological involvement: presentation of four cases. Clin. Exp. Rheumatol 2011, 29:S64-S67.
114. Siva A., Saip S. The spectrum of nervous system involvement in Behçet's syndrome and its differential diagnosis. J. Neurol. 2009, 256:513-529.
115. Siva A., Ozdogan H., Yazici H., et al. Headache, neuro-psychiatric and computerized tomography findings in Behçet's syndrome. Recent Advances in Behçet's Disease 1986, 247-254. Royal Society of Medicine Service, London. T. Lehner, C.G. Barnes (Eds.).
116. Siva A., Kantarci O.H., Saip S., et al. Behçet's disease: diagnostic and prognostic aspects of neurological involvement. J. Neurol. 2001, 248:95-103.
117. Siva A., Altfintaş A., Saip S. Behçet's syndrome and the nervous system. Curr. Opin. Neurol. 2004, 17:347-357.
118. Susac J.O., Egan R.A., Rennebohm R.M., et al. Susac's syndrome: 1975-2005 microangiopathy/autoimmune endotheliopathy. J. Neurol. Sci. 2007, 257:270-272.
119. Takeuchi A., Kodama M., Takatsu M., et al. Mononeruritis multiplex in incomplete Behçet's disease: a case report and the review of the literature. Clin. Rheumatol. 1989, 8:375-380.
120. Tasçi B., Direskeneli H., Serdaroglu P., et al. Humoral immune response to mycobacterial heat shock protein (hsp) 65 in the cerebrospinal fluid of neuro-Behçet's patients. Clin. Exp. Immunol. 1998, 113:100-104.
121. Taskapilioglu O., Seferoglu M., Akkaya C., et al. Delayed diagnosis of a neuroBehçet patient with only brainstem and cerebellar atrophy: literature review. J. Neurol. Sci. 2009, 277:160-163.
122. Touma Z., Farra C., Hamdan A., et al. TNF polymorphisms in patients with BD: a meta-analysis. Arch. Med. Res. 2010, 41:142-146.
123. Tunc R., Saib S., Siva A., et al. Cerebral venous thrombosis is associated with major vessel disease in Behçet's syndrome. Ann. Rheum. Dis. 2004, 63:1693-1694.
124. Tunc T., Ortapamuk H., Naldoken S., et al. Subclinical neurological involvement in Behçet's disease. Neurol. India 2006, 54:408-411.
125. Uluduz D., Kürtüncü M., Yapici Z., et al. Clinical characteristics of pediatric-onset neuro-Behçet disease. Neurology 2011, 77:1900-1905.
126. Urbaniak P., Hasker P., Kretzschmar S. Refractory neuro-Behçet treated by tocilizumab: a case report. Clin. Exp. Rheumatol 2012, 30(Suppl):S73-S75.
127. Watanabe N., Seto H., Sato S., et al. Brain SPECT with neuro-Behçet disease. Clin. Nucl. Med. 1995, 20:61-64.
128. Wechsler B., Vidailhet M., Bousser M.G., et al. Cerebral venous sinus thrombosis in Behçet's disease: long term follow-up of 25 cases. Neurology 1992, 42:614-618.
129. Yazici H. Behçet syndrome: an update. Curr. Rheumatol. Rep. 2003, 5:195-219.
130. Yazici H., Fresko I., Yurdakul S. Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat. Clin. Pract. Rheumatol 2007, 3:151-155.
131. Yazici H., Ugurlu S., Seyahi E. Behçet syndrome: is it one condition?. Clin. Rev. Allergy. Immunol. 2012, 43:275-280.
132. Yazici Y., Yurdakul S., Yazici H. Behçet's syndrome. Curr. Rheumatol. Rep. 2010, 12:429-435.
133. Yesilot N., Shehu M., Oktem-Tanor O., et al. Silent neurological involvement in Behçet's disease. Clin. Exp. Rheumatol. 2006, 24:S65-S70.
134. Yesilot N., Mutlu M., Gungor O., et al. Clinical characteristics and course of spinal cord involvement in Behçet's disease. Eur. J. Neurol. 2007, 14:729-737.
135. Yesilot N., Bahar S., Yilmazer S., et al. Cerebral venous thrombosis in Behçet's disease compared to those associated with other etiologies. J. Neurol. 2009, 256:1134-1142.
136. Zouboulis C.C., Kotter I., Djawari D., et al. Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei. Med. J. 1997, 38:411-422.